Clinical Trials
15 trialsNCT05891197 2025-07-01
START
Lyell Immunopharma, Inc.
Terminated
NCT05645744 2024-07-22
Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.
Mustang Bio
Terminated
NCT04995575 2024-02-22
MINDACTRelapse
European Organisation for Research and Treatment of Cancer - EORTC
Terminated
NCT04234399 2024-01-24
Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy
University of Vermont
Terminated
NCT00019643 2023-10-31
Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer
National Institutes of Health Clinical Center (CC)
Terminated
NCT03410407 2022-10-26
AML1617
Gruppo Italiano Malattie EMatologiche dell'Adulto
Terminated
NCT01881451 2022-02-17
Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer
British Columbia Cancer Agency
Terminated
NCT00949052 2018-08-16
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Vanderbilt-Ingram Cancer Center
Terminated
NCT01326728 2018-06-06
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
National Institutes of Health Clinical Center (CC)
Terminated
NCT01884129 2015-12-10
CTCHNSCC01
Chang Gung Memorial Hospital
Terminated
NCT00008216 2014-06-06
Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
Columbia University
Terminated
NCT00957736 2013-05-14
Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
Terminated
NCT00288275 2012-10-05
Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
Precision Therapeutics
Terminated
NCT00669422 2012-10-05
ChemoFx® PRO - A Post-Market Data Collection Study
Precision Therapeutics
Terminated
NCT01271959 2012-10-05
A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study
Precision Therapeutics
Terminated